

Toll-Free: (800) 266-7207  For Domestic | Intl: (404) 496-4049

  • Follow
  • Follow
  • Follow

Invest Now

  • Home
  • About Us
    • Our Tribe
    • Our Mission
    • Our Values
    • Our Future
  • Medical & Wellness Testing
  • Contact Us
  • News
  • Invest Now
  • Home
  • About Us
    • Our Tribe
    • Our Mission
    • Our Values
    • Our Future
  • Contact Us
  • Medical & Wellness Testing
  • News
  • Invest Now
Beyond the Pandemic: Confronting the Triple Menace of COVID-19, Flu, and RSV with Innovative Testing Solutions

Beyond the Pandemic: Confronting the Triple Menace of COVID-19, Flu, and RSV with Innovative Testing Solutions

Mar 19, 2024 | Artificial Intelligence, Covid-19, Flu, Infectious Disease, Lab Developed Test (LDT), RSV | 0 comments

Discover how artificial intelligence and advanced lab-developed tests are poised to transform our understanding, testing, and treatment of future variants more efficiently. The clock has run out on America’s free COVID-19 testing program. Two weeks ago, on March...

Study: Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients

Nov 1, 2021 | News | 0 comments

By: Eric M. Liotta,Ayush Batra,Jeffrey R. Clark,Nathan A. Shlobin,Steven C. Hoffman,Zachary S. Orban,Igor J. Koralnik Annals of Clinical and Translational Neurology Published:  05 October 2020 Full Study Covid-19 can involve multiple organs including the nervous...

Study: Optical Biosensors for Virus Detection: Prospects for SARS-CoV-2/COVID-19

Nov 1, 2021 | News | 0 comments

By: Hemanth Maddali,Catherine E. Miles,Prof. Joachim Kohn,Prof. Deirdre M. O’Carroll, Chemistry Europe Published: 29 October 2020 Full Study Optical biosensors have led to significant advancements in virus detection and imaging capabilities. Coupled with...

Study: SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Nov 1, 2021 | News | 0 comments

By: Michael A. Johansson, PhD; Talia M. Quandelacy, PhD, MPH; Sarah Kada, PhD; JAMA Netw Open. 2021;4(1) Published:  January 07 2021 Full Study Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiology of coronavirus disease 2019 (COVID-19), is...

Study: Comparative evaluation of 19 reverse transcription loop-mediated isothermal amplification assays for detection of SARS-CoV-2

Nov 1, 2021 | News | 0 comments

By: Yajuan Dong, Xiuming Wu, Shenwei Li, Renfei Lu, Yingxue Li, Zhenzhou Wan, Jianru Qin, Guoying Yu, Xia Jin & Chiyu Zhang Scientific Reports volume 11, Article number: 2936 (2021) Published:  03 February 2021 Full Study Coronavirus disease 2019 (COVID-19) caused...
« Older Entries

Recent Posts

  • Beyond the Pandemic: Confronting the Triple Menace of COVID-19, Flu, and RSV with Innovative Testing Solutions
  • Unseen Casualties of the Pandemic: How COVID-19 Led to Thousands of Missed Prostate Cancer Diagnoses in England
  • Unmasking Chronic Anxiety’s 95% Misdiagnosis Rate & Need for Precision Beyond Self-Recognition
  • Essential Knowledge about Prostate Cancer for Patients
  • Empowering Health Advocates: How Clear Health Pass is Revolutionizing Preventive Care with Ethical AI

Recent Comments

No comments to show.

ABOUT US

Clear Health Pass™ LLC acts as Authorized Representative of tribal, federally chartered corporations formed under Section 17 of the Indian Reorganization Act (IRA), U.S.C. Title 25.

(800) 266-7207
(404) 496-4049

 

 

OUR TESTS

  • Clear Health Pass MDHeartPro
  • Clear Health Pass MDDiabeticPro
  • Clear Health Pass MDGeneticPro Women’s Health
  • Clear Health Pass MDAllergyPro
  • Clear Health Pass MDDrugPro
  • Clear Health Pass NIPT

OUR PARTNERS

Under Disclaimers & Regulatory Disclosures

 

    • Use of Artificial Intelligence (AI)
    • CLIA Certification and Laboratory Accreditation
    • HIPAA Compliance and Data Security
    • FDA Compliance for Laboratory-Developed Tests 
    • Tribal Sovereignty and Compliance
    • Medical Disclaimer for Lab Testing & Result Interpretation
    • Quality Assurance Commitment
    • Third-Party Vendor Compliance
    • Safe Harbor Statement
    • Privacy Policy | Terms and Conditions

 

© 2022-2025 Clear Health Pass Holdings, LLC. All rights reserved. Clear Health Pass, DrugPro, GeneticPro, DiabeticPro, and HeartPro are trademarks of Clear Health Pass Holdings, LLC. Unauthorized use of these trademarks is strictly prohibited.